BioSpace News Archive

New applicator provides surgeons with greater control during ENT surgeries to help foster improved outcomes for patients

LPT99 is the company’s lead investigational drug candidate targeting prevention and treatment of hearing loss.

CarePredict, the leading digital health company for senior care announced today they have been selected as one of the five companies to win the Consumer Technology Association (CTA) Foundation’s Accessibility Contest at CES 2019.

The American College of Prosthodontists (ACP) is pleased to announce John A. Sorensen, DMD, PhD, FACP, as the recipient of the 2018 Clinician/Researcher Award, recognizing outstanding contributions to academic dentistry, prosthodontics and the sciences.

Change Healthcare announced that it has acquired intellectual property (IP) and other key assets from PokitDok, Inc., a platform-as-a-service company for healthcare.

TriNetX, the global health research network that revolutionizes clinical research and enables discoveries through the creation of real-world evidence (RWE), today announced the results of a study confirming that the TriNetX platform successfully leverages real-world data (RWD) to generate RWE to replicate results from randomized clinical trials (RCTs).

LakePharma, Inc., the leading US-based biologics company specializing in antibody & protein engineering, cell line development, and protein production, announced today that their cGMP microBiomanufacturing™ Center is now commercially manufacturing plasmid DNA at their Hopkinton, MA location, which is in close proximity to the Cambridge and Boston areas.

IFM Therapeutics (IFM), a privately held biopharmaceutical company focused on developing therapies that modulate novel targets in the innate immune system, today announced the discovery of new immune system triggers that are associated with certain inflammatory diseases.

NowRx, an on-demand pharmacy that provides same-day and same-hour delivery of prescription medications, today announced that it has been selected as a finalist for the 2018 TripleTree iAwards.

VASCADE MVP is the first vessel closure technology designed for electrophysiology procedures – and proven by electrophysiology physicians in a multi-center, randomized, controlled clinical trial.